Gaois

Cóip statach de shonraí a easpórtáiltear ó IATE ó am go chéile atá sa chnuasach seo. Níor cheart glacadh leis gurb ionann i gcónaí an t-eolas a thugtar faoi iontráil anseo agus a bhfuil sa leagan reatha den iontráil ar IATE. Is féidir an leagan reatha sin a cheadú ach cliceáil ar an nasc atá ar thaobh na láimhe deise ag barr gach iontrála. Breis eolais »

4 thoradh

  1. SOCIAL QUESTIONS|health|pharmaceutical industry · PRODUCTION, TECHNOLOGY AND RESEARCH|research and intellectual property|research
    táirge íocshláinte imscrúdaitheach Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Prüfpräparat
    de
    Sainmhíniú pharmazeutische Form eines Wirkstoffs oder Placebos, die in einer klinischen Prüfung getestet oder als Referenzsubstanz verwendet wird Tagairt "Richtlinie 2001/20/EG des Europäischen Parlaments und des Rates vom 4. April 2001 zur Angleichung der Rechts- und Verwaltungsvorschriften der Mitgliedstaaten über die Anwendung der guten klinischen Praxis bei der Durchführung von klinischen Prüfungen mit Humanarzneimitteln CELEX:32001L0020/DE"
    investigational medicinal product | IMP | investigational product | medicinal product for trial | investigational medicine
    en
    Sainmhíniú "medicinal product which is being tested or used as a reference, including as a placebo, in a clinical trial" Tagairt "Regulation (EU) No 536/2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC"
    Nóta Does not include medicinal products used for background treatment, challenge agents, rescue medication, or medicinal products used to assess end-points in a clinical trial.
    médicament expérimental
    fr
    Sainmhíniú médicament expérimenté ou utilisé comme référence, y compris en tant que placebo, lors d'un essai clinique Tagairt "Règlement (UE) n o 536/2014 relatif aux essais cliniques de médicaments à usage humain et abrogeant la directive 2001/20/CE"
  2. SOCIAL QUESTIONS|health|pharmaceutical industry
    táirge íocshláinte imscrúdaitheach diagnóiseach Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    diagnostisches Prüfpräparat
    de
    diagnostic investigational medicinal product
    en
    Sainmhíniú "investigational medicinal product [ IATE:2146586 ] used to make a medical diagnosis" Tagairt COM-EN, based on: COM-Internal document: SANCO-2012-80155-00-01 Regulation on clinical trials on medicinal products for human use
    médicament expérimental de diagnostic
    fr
    Sainmhíniú médicament expérimental utilisé pour réaliser un diagnostic Tagairt COM-FR, d'après:COM-Document interne: SANCO-2012-80155-00-04Règlement relatif aux essais cliniques de médicaments à usage humain
  3. SOCIAL QUESTIONS|health|pharmaceutical industry
    táirge íocshláinte imscrúdaitheach ardteiripe Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Prüfpräparat für neuartige Therapien
    de
    Sainmhíniú Prüfpräparat, das ein Arzneimittel für neuartige Therapien im Sinne des Artikels 2 Absatz 1 der Verordnung (EG) Nr. 1394/2007 des Europäischen Parlaments und des Rates ist Tagairt COM-Internes Dokument SANCO-2012-80155-02-01
    advanced therapy investigational medicinal product
    en
    Sainmhíniú "advanced therapy medicinal product [ IATE:2228848 ] which is also an investigational medicinal product [ IATE:2146586 ]" Tagairt "COM-EN, based on:Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC, CELEX:52012PC0369/EN"
    médicament expérimental de thérapie innovante
    fr
    Sainmhíniú "médicament expérimental correspondant à un médicament de thérapie innovante [ IATE:2228848 ]" Tagairt COM-Document interne: SANCO-2012-80155-00-04Règlement relatif aux essais cliniques de médicaments à usage humain
  4. SOCIAL QUESTIONS|health|pharmaceutical industry · PRODUCTION, TECHNOLOGY AND RESEARCH|research and intellectual property|research|scientific research
    ceist sábháilteachta i ndáil le táirge íocshláinte imscrúdaitheach Tagairt "Rialachán Cur Chun Feidhme (AE) 2022/20 lena leagtar síos rialacha maidir le cur i bhfeidhm Rialachán (AE) Uimh. 536/2014 ó Pharlaimint na hEorpa agus ón gComhairle a mhéid a bhaineann le bunú na rialacha agus na nósanna imeachta um chomhar idir na Ballstáit sa mheasúnú sábháilteachta ar thrialacha cliniciúla, CELEX:32022R0020/GA Faomhadh an téarma seo mar chuid de Thionscadal Lex"
    ga
    Sainmhíniú faisnéis maidir le sábháilteacht an táirge íocshláinte imscrúdaithigh a d’fhéadfadh tionchar diúltach a bheith aige ar a chóimheas tairbhe-riosca nó lena mbaineann impleacht sláinte poibl Tagairt "Rialachán Cur Chun Feidhme (AE) 2022/20 lena leagtar síos rialacha maidir le cur i bhfeidhm Rialachán (AE) Uimh. 536/2014 ó Pharlaimint na hEorpa agus ón gComhairle a mhéid a bhaineann le bunú na rialacha agus na nósanna imeachta um chomhar idir na Ballstáit sa mheasúnú sábháilteachta ar thrialacha cliniciúla, CELEX:32022R0020/GA"
    Sicherheitsbedenken in Bezug auf ein Prüfpräparat
    de
    Sainmhíniú "Informationen zur Sicherheit eines Prüfpräparats mit potenziell negativen Auswirkungen auf sein Nutzen-Risiko-Verhältnis oder Folgen für die öffentliche Gesundheit" Tagairt COM-internes Dokument: SANTE-2021-81060 (klinische Prüfungen)
    safety concern in relation to an investigational medicinal product
    en
    Sainmhíniú "information on the safety of the investigational medicinal product with potential negative impact on its benefit-risk ratio or with a public health implication" Tagairt "Commission Implementing Regulation (EU) 2022/20 laying down rules for the application of Regulation (EU) No 536/2014 as regards setting up the rules and procedures for the cooperation of the Member States in safety assessment of clinical trials"